Article Text

Download PDFPDF

PWE-058 Outcomes of using therapeutic drug monitoring to guide switching from originator infliximab to biosimilar infliximab
  1. J Veryan1,
  2. J Pexton,
  3. R Boulton-Jones,
  4. A Clarke,
  5. G Curry,
  6. E Nowell,
  7. J Macdonald,
  8. JP Seenan
  1. Gastroenterology, Queen Elizabeth University Hospital, Glasgow, UK

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.